Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 28, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	41,009	52,994	15,643	11,641	98,268	-
Market Cap Growth	153.62%	238.77%	34.38%	-88.15%	-	-
Enterprise Value	40,219	53,964	18,909	14,449	102,406	-
Last Close Price	808.55	1044.85	383.25	285.20	2407.55	-
PE Ratio	36.98	57.50	33.77	-	-	-
PS Ratio	4.55	6.47	2.35	2.08	21.83	-
PB Ratio	3.35	4.53	2.27	1.80	15.05	-
P/TBV Ratio	3.40	4.59	2.27	1.80	15.06	-
P/FCF Ratio	-	86.62	-	14.91	427.59	-
P/OCF Ratio	-	42.06	85.30	12.59	416.64	-
EV/Sales Ratio	4.46	6.59	2.84	2.58	22.75	-
EV/EBITDA Ratio	40.16	49.33	22.57	27.21	175.38	-
EV/EBIT Ratio	47.15	69.52	65.22	-	-	-
EV/FCF Ratio	-	88.21	-	18.51	445.59	-
Debt / Equity Ratio	0.14	0.12	0.48	0.41	0.69	0.74
Debt / EBITDA Ratio	1.65	1.23	3.96	5.05	7.75	12.39
Debt / FCF Ratio	-	2.21	-	3.43	19.70	7.40
Asset Turnover	-	0.59	0.57	0.48	0.33	0.21
Inventory Turnover	-	2.04	2.00	2.01	1.64	1.44
Quick Ratio	-	0.79	0.65	0.73	1.18	0.90
Current Ratio	-	3.04	1.35	1.65	3.87	3.25
Return on Equity (ROE)	-	9.92%	7.95%	-9.29%	-13.43%	-225.00%
Return on Assets (ROA)	-	3.49%	1.55%	-1.80%	-2.34%	-1.99%
Return on Capital (ROIC)	4.02%	4.17%	1.87%	-2.10%	-2.59%	-2.34%
Return on Capital Employed (ROCE)	-	6.00%	3.40%	-	-	-
Earnings Yield	2.70%	1.74%	2.96%	-0.17%	-1.19%	-
FCF Yield	-	1.15%	-4.26%	6.71%	0.23%	-
Buyback Yield / Dilution	-10.51%	-18.49%	-	-	-9914.82%	0.15%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.